Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer’s Disease-Reference-Cited by-同舟云学术

Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer’s Disease

Published:2019-02-04 Issue:4 Volume:10 Page:469-474
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

De Simone Angela¹,La Pietra Valeria²,Betari Nibal¹,Petragnani Nicola³,Conte Mariarosaria⁴,Daniele Simona⁵,Pietrobono Deborah⁵,Martini Claudia⁵^ORCID,Petralla Sabrina⁶,Casadei Raffaella¹,Davani Lara¹,Frabetti Flavia⁷,Russomanno Pasquale²,Novellino Ettore²^ORCID,Montanari Serena¹,Tumiatti Vincenzo¹,Ballerini Patrizia³,Sarno Federica⁸,Nebbioso Angela⁸,Altucci Lucia⁸,Monti Barbara⁶,Andrisano Vincenza¹,Milelli Andrea¹^ORCID

Affiliation:

1. Department for Life Quality Studies, Alma Mater Studiorum—University of Bologna, Corso d’Augusto 237, 47921 Rimini, Italy

2. Department of Pharmacy, Federico II University of Naples, Via D. Montesano 49, 80131 Naples, Italy

3. Department of Psychological, Health and Territorial Sciences, “G. d’Annunzio” University of Chieti-Pescara, Via dei Vestini 32, 66100 Chieti, Italy

4. IRCCS, SDN, Via E. Gianturco 113, 80143 Naples, Italy

5. Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126 Pisa, Italy

6. Department of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy

7. Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum-University of Bologna, Via Belmeloro 8, 40126 Bologna, Italy

8. Department of Precision Medicine, University of Campania Luigi Vanvitelli, Vico L. De Crecchio 7, 80138 Naples, Italy

Funder

FP7 Health

Worldwide Cancer Research

Ministero dell?Istruzione, dell?Universit? e della Ricerca

Associazione Italiana per la Ricerca sul Cancro

Universit? di Bologna

Consiglio Nazionale delle Ricerche